Evidence map›Paper›PMID 41626093›Full record

ArticleClinical case reports2026

Epstein-Barr Virus and Hepatitis E Virus in an Immunocompetent Adult: A Rare Case Report.

Philippe Attieh, Antonio Al Hazzouri, Karam Karam, Ihab I El Hajj, Elias Fiani

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Philippe AttiehDepartment of Internal Medicine University of Balamand Beirut Lebanon.
Antonio Al HazzouriDepartment of Internal Medicine University of Balamand Beirut Lebanon.
Karam KaramDepartment of Gastroenterology and Hepatology University of Balamand Beirut Lebanon.ORCID https://orcid.org/0009-0001-1914-320X
Ihab I El HajjDepartment of Gastroenterology and Hepatology University of Balamand Beirut Lebanon.ORCID https://orcid.org/0000-0001-5835-7940
Elias FianiDepartment of Gastroenterology and Hepatology University of Balamand Beirut Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epstein-Barr virus (EBV) and Hepatitis E virus (HEV) are two distinct viral pathogens known to affect the liver. While EBV commonly causes mild, self-limited hepatitis, and HEV is the leading cause of acute viral hepatitis globally, co-infection with both viruses is exceedingly rare. This case report describes a 55-year-old previously healthy male who presented with right upper quadrant abdominal pain and generalized fatigue. Laboratory investigations revealed markedly elevated transaminases and slightly increased bilirubin, suggesting mixed hepatocellular and cholestatic liver injury. Initial serologies showed positive EBV IgG and borderline IgM, confirmed by a low positive EBV DNA PCR. While awaiting HEV testing, the patient was managed supportively. On day four, HEV IgM returned positive and EBV DNA rose to 15,500 copies/mL, confirming concomitant infection. Imaging revealed periportal edema and splenomegaly with no biliary obstruction. Supportive care led to a steady clinical improvement and normalization of liver enzymes by day 14. The patient was discharged in stable condition with full clinical and biochemical recovery. This case highlights the importance of considering dual viral infections in patients with significant hepatic enzyme elevation and non-specific systemic symptoms. Although rare, concurrent EBV and HEV infection can present with significant liver inflammation but may still follow a self-limiting course in immunocompetent individuals. Awareness of such co-infections can prevent misdiagnosis, avoid unnecessary interventions, and emphasize the role of supportive care. Additionally, this case underscores the need for comprehensive viral screening when evaluating unexplained hepatitis in otherwise healthy individuals. Early recognition ensures appropriate management and favorable outcomes.

Indexed as

co‐infectionEpstein–Barr virushepatitis E virusliver enzyme elevation

Identifiers

PMID41626093
PMCPMC12859684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.